A detailed history of Jane Street Group, LLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 45,962 shares of MORF stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,962
Previous 101,888 54.89%
Holding current value
$1.57 Million
Previous $2.94 Million 45.04%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$26.64 - $40.31 $1.49 Million - $2.25 Million
-55,926 Reduced 54.89%
45,962 $1.62 Million
Q4 2023

Feb 14, 2024

SELL
$19.95 - $31.0 $162,772 - $252,929
-8,159 Reduced 7.41%
101,888 $2.94 Million
Q3 2023

Nov 14, 2023

BUY
$21.33 - $59.42 $1.85 Million - $5.14 Million
86,580 Added 368.94%
110,047 $2.52 Million
Q2 2023

Aug 14, 2023

SELL
$34.33 - $62.11 $476,088 - $861,341
-13,868 Reduced 37.14%
23,467 $1.35 Million
Q1 2023

May 15, 2023

BUY
$26.01 - $48.69 $713,194 - $1.34 Million
27,420 Added 276.55%
37,335 $1.41 Million
Q4 2022

Feb 14, 2023

BUY
$24.14 - $30.37 $30,730 - $38,661
1,273 Added 14.73%
9,915 $265,000
Q3 2022

Nov 14, 2022

SELL
$22.23 - $33.37 $36,590 - $54,927
-1,646 Reduced 16.0%
8,642 $245,000
Q3 2022

Nov 14, 2022

SELL
$22.23 - $33.37 $36,590 - $54,927
-1,646 Reduced 16.0%
8,642 $245,000
Q2 2022

Aug 16, 2022

BUY
$19.74 - $43.01 $203,085 - $442,486
10,288 New
10,288 $223,000
Q1 2022

May 17, 2022

SELL
$36.25 - $52.02 $188,028 - $269,827
-5,187 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$43.27 - $65.72 $137,858 - $209,383
-3,186 Reduced 38.05%
5,187 $246,000
Q3 2021

Nov 16, 2021

BUY
$53.61 - $67.5 $448,876 - $565,177
8,373 New
8,373 $474,000
Q2 2021

Aug 16, 2021

SELL
$45.13 - $64.99 $496,384 - $714,825
-10,999 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$29.77 - $84.85 $327,440 - $933,265
10,999 New
10,999 $696,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.